Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics

被引:3
|
作者
Bertelmann, Thomas [1 ]
Berndzen, Lars [1 ]
Raber, Thomas [2 ]
Pfeiffer, Sebastian [3 ]
Leha, Andreas [4 ]
Paul, Christoph [5 ]
Feltgen, Nicolas [1 ]
Bemme, Sebastian [1 ]
机构
[1] Univ Med Ctr Goettingen, Dept Ophthalmol, Robert Koch Str 40, D-37075 Gottingen, Germany
[2] Oxurion NV, Leuven, Belgium
[3] Univ Med Ctr Goettingen, UMG Study Ctr, Gottingen, Germany
[4] Univ Med Ctr Goettingen, Dept Med Biometry & Stat Bioinformat, Gottingen, Germany
[5] Philipps Univ Marburg, Dept Ophthalmol, Marburg, Germany
关键词
RESOLUTION; ADHESION; INTERFACE; EFFICACY;
D O I
10.1038/s41598-021-03509-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The primary objective was to create and establish a new formula that predicts the individual probability of macular hole closure for eyes with full thickness macular holes (FTMH) accompanied by vitreomacular traction (VMT) which received enzymatic vitreolysis using intravitreally administered ocriplasmin. The secondary objective was to evaluate the forecast reliability of a previously published formula for VMT resolution in VMT-only eyes (Odds(IVO-Success) = e(Intercept )x OR(years )x ORln(mu m); Probability(IVO-Success) = Odds(IVO-Success)/(Odds(IVO-Success) + 1)) on VMT resolution using the current dataset of eyes with FTMH accompanied by VMT. Retrospective analysis of the OASIS, ORBIT, and INJECT-studies. Patients with FTMH and VMT with complete information (n = 213) were included. The effect of gender, age, FTMH diameter, lens status and the presence of epiretinal membranes (ERM) on FTMH closure was assessed using separate univariate logistic regression analyses. With regard to VMT release separate univariate regression analyses were carried out and results were compared with formerly published data of VMT resolution in eyes with VMT only. Overall, 126 eyes (63%) experienced VMT resolution within 28 days. Younger age (p < 0.0001) and VMT diameter (p = 0.041) had a significant impact on VMT release. Overall, 81 eyes (38%) treated with ocriplasmin showed FTMH closure within 28 days. Univariate analysis of the different predictors analyzed revealed that FTMH diameter < 250 mu m had a significant impact on treatment success (p = 0.0495). It was not possible to calculate and establish a new multivariate formula that can predict the individual FTMH closure probability for eyes with FTMHs and VMT. However, the results of VMT release prediction in eyes with FTMHs accompanied by VMT matched the prediction of VMT release in eyes with VMT only when using the previously published formula. All in all, predictors for calculating the individual probability of VMT resolution on the one hand and FTMH closure on the other hand are different suggesting diverse pathophysiological mechanisms.
引用
收藏
页数:8
相关论文
共 11 条
  • [1] Morphological Reconstitution and Persistent Changes After Intravitreal Ocriplasmin for Vitreomacular Traction and Macular Hole
    Zandi, Souska
    Freiberg, Florentina
    Vaclavik, Veronika
    Pfister, Isabel B.
    Traine, Peter G.
    Kaya, Cagdas
    Michels, Stephan
    Garweg, Justus G.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 36 (02) : 126 - 132
  • [2] Initial Clinical Experiences Using Ocriplasmin for the Treatment of Vitreomacular Traction with or without a Macular Hole
    Lenk, J.
    Matthe, E.
    Ventzke, S.
    Pillunat, L. E.
    Sandner, D.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2018, 235 (01) : 73 - 80
  • [3] Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance
    Muqit, Mahiul M. K.
    Hamilton, Robin
    Ho, Jason
    Tucker, Sally
    Buck, Helen
    PLOS ONE, 2018, 13 (05):
  • [4] OPTICAL COHERENCE TOMOGRAPHY FEATURES ASSOCIATED WITH VITREOMACULAR TRACTION RELEASE AND MACULAR HOLE SIZE PROGRESSION FOLLOWING TREATMENT WITH OCRIPLASMIN
    Johannigmann-Malek, Navid
    Iannetta, Danilo
    Zheng, Yalin
    Kaye, Stephen B.
    Groselli, Sofia
    Kirchmair, Katharina
    Dervenis, Nikolaos
    Issa, Peter Charbel
    Baumann, Carmen
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2024, 44 (11): : 1923 - 1930
  • [5] OUTER RETINA REFLECTIVITY CHANGES ON SD-OCT AFTER INTRAVITREAL OCRIPLASMIN FOR VITREOMACULAR TRACTION AND MACULAR HOLE
    Quezada-Ruiz, Carlos
    Pieramici, Dante J.
    Nasir, Ma'an
    Rabena, Melvin
    Steinle, Nathan
    Castellarin, Alessandro A.
    Dhoot, Dilsher
    Couvillion, Stephen
    See, Robert F.
    Avery, Robert L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (06): : 1144 - 1150
  • [6] Complications of intravitreal ocriplasmin for vitreomacular traction and macular hole: a prospective spectral-domain optical coherence tomography study
    Chatziralli, Irini P.
    Theodossiadis, George P.
    Parikakis, Efstratios
    Datseris, Ioannis
    Theodossiadis, Panagiotis
    CUTANEOUS AND OCULAR TOXICOLOGY, 2016, 35 (04) : 263 - 269
  • [7] Ocriplasmin use for vitreomacular traction and macular hole: A meta-analysis and comprehensive review on predictive factors for vitreous release and potential complications
    Chatziralli, Irini
    Theodossiadis, George
    Xanthopoulou, Paraskevi
    Miligkos, Michael
    Sivaprasad, Sobha
    Theodossiadis, Panagiotis
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (07) : 1247 - 1256
  • [8] Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study
    Chatziralli, Irini
    Theodossiadis, George
    Parikakis, Efstratios
    Datseris, Ioannis
    Theodossiadis, Panagiotis
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (02) : 223 - 233
  • [9] ASSOCIATION BETWEEN ANATOMICAL RESOLUTION AND FUNCTIONAL OUTCOMES IN THE MIVI-TRUST STUDIES USING OCRIPLASMIN TO TREAT SYMPTOMATIC VITREOMACULAR ADHESION/VITREOMACULAR TRACTION, INCLUDING WHEN ASSOCIATED WITH MACULAR HOLE
    Gandorfer, Arnd
    Benz, Matthew S.
    Haller, Julia A.
    Stalmans, Peter
    Pakola, Stephen J.
    Girach, Aniz
    Kampik, Anselm
    Toth, Cynthia A.
    Jaffe, Glenn J.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (06): : 1151 - 1157
  • [10] Ocriplasmin for treatment of vitreomacular traction and macular hole: A systematic literature review and individual participant data meta-analysis of randomized, controlled, double-masked trials
    Jackson, Timothy L.
    Haller, Julia
    Blot, Koenraad H.
    Duchateau, Luc
    Lescrauwaet, Benedicte
    SURVEY OF OPHTHALMOLOGY, 2022, 67 (03) : 697 - 711